ML-PrediCare

· Optimata Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ML-PrediCare, covering 2016-09-27 to 2016-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy

See pricing